Assessing the magnitude of changes from protocol to publication—a survey on Cochrane and non-Cochrane Systematic Reviews

Author:

Siebert Maximilian1,Caquelin Laura2,Madera Meisser3,Acosta-Dighero Roberto4,Naudet Florian25,Roqué Marta67

Affiliation:

1. Stanford University, Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

2. Université de Rennes, Univ Rennes, CHU Rennes, Inserm, Centre d’investigation clinique de Rennes (CIC1414), Service de pharmacologie clinique, Institut de recherche en santé, environnement et travail (Irset), UMR S 1085, EHESP, Rennes, France

3. Faculty of Dentistry at the University of Cartagena, Department of Research, Cartagena, Colombia

4. Universidad de Valparaíso, Interdisciplinary Centre for Health Studies (CIESAL), Valparaíso, Chile

5. Institut Universitaire de France, Paris, France

6. Sant Pau Biomedical Research Institute (IIB-Sant Pau), Iberoamerican Cochrane Centre, Barcelona, Spain

7. CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain

Abstract

Objective To explore differences between published reviews and their respective protocols in a sample of 97 non-Cochrane Systematic Reviews (non-CSRs) and 97 Cochrane Systematic Reviews (CSRs) in terms of PICOS (Patients/Population, Intervention, Comparison/Control, Outcome, Study type) elements and the extent to which they were reported. Study Design and Setting We searched PubMed and Cochrane databases to identify non-CSRs and CSRs that were published in 2018. We then searched for their corresponding Cochrane or PROSPERO protocols. The published reviews were compared to their protocols. The primary outcome was changes from protocol to review in terms of PICOS elements. Results We identified a total of 227 changes from protocol to review in PICOS elements, 1.11 (Standard Deviation (SD), 1.22) changes per review for CSRs and 1.23 (SD, 1.12) for non-CSRs per review. More than half of each sub-sample (54.6% of CSRs and 67.0% of non-CSRs) (Absolute Risk Reduction (ARR) 12.4% [−1.3%; 26.0%]) had changes in PICOS elements. For both subsamples, approximately a third of all changes corresponded to changes related to primary outcomes. Marked differences were found between the sub-samples for the reporting of changes. 95.8% of the changes in PICOS items were not reported in the non-CSRs compared to 42.6% in the CSRs (ARR 53.2% [43.2%; 63.2%]). Conclusion CSRs showed better results than non-CSRs in terms of the reporting of changes. Reporting of changes from protocol needs to be promoted and requires general improvement. The limitations of this study lie in its observational design. Registration: https://osf.io/6j8gd/.

Publisher

PeerJ

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference32 articles.

1. Systematic reviews: synthesis of best evidence for clinical decisions;Cook;Annals of Internal Medicine,1997

2. Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis;Dwan;BMJ Open,2013

3. Cochrane handbook for systematic reviews of interventions—cochrane training [Internet]. 6.22021;Higgins,2023

4. Rmisc: Ryan miscellaneous [Internet]. [cited 2023 May 16];Hope,2022

5. Inconsistencies in study eligibility criteria are common between non-Cochrane systematic reviews and their protocols registered in PROSPERO;Hu;Research Synthesis Methods,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. What is the vibration of effects?;BMJ Evidence-Based Medicine;2024-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3